United States· US:0220-0552_253cfb90-3f81-fb07-e063-6294a90a50cf
Artemisia vulgaris
A medicinal product containing artemisia vulgaris root, registered in United States by Boiron.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ARTEMISIA VULGARIS ROOT
- Manufacturer
- Boiron
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc11022005524130 [hp_C] in 1 TUBE (0220-0552-41)
- ndc110220-0552-41
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Artemisia vulgaris root in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- GermanyAlk-Prick SqAlk-Abelló Arzneimittel Gmbh
- SwitzerlandAllergovit Artemisia
- United KingdomMugwort (Artemisia vulgaris) pollen 10,000DU/ml ODC solution for skin prick testAllergy Therapeutics (UK) Ltd
- NetherlandsArtemisia vulgarisBoiron
Authorised across Europe · EMA
The same active substance is authorised in 9 EEA countries. Names it is sold under:
- Czechia · Soluprick Sq
- Germany · Alk-Prick Sq, Gemeiner Beifuß Hal Allergy
- Denmark · Soluprick Sq
- Finland · Soluprick Sq
- United Kingdom (Northern Ireland) · Soluprick Sq
- Netherlands · Soluprick Sq
- Poland · Bylica Pospolita Prick Test Hal Allergy
- Sweden · Soluprick Sq
- Slovakia · Soluprick
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dfac2edd-f96c-4425-8114-1f835bc337fc GET /v1/drugs/dfac2edd-f96c-4425-8114-1f835bc337fc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "30",
"substance": "ARTEMISIA VULGARIS ROOT",
"productndc": "0220-0552",
"dosage_form": "PELLET",
"dea_schedule": null,
"strength_unit": "[hp_C]/30[hp_C]",
"application_number": null,
"marketing_category": "UNAPPROVED HOMEOPATHIC"
}See everything about artemisia vulgaris root.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.